← Back to Search

Enhanced Bidirectional Text Reminders for Respiratory Infection (LADHS Trial)

N/A

Waitlist Available

Led By Peter Szilagyi

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

LADHS Trial Summary

This trial is testing whether sending text reminders with additional information to people who are due for a flu vaccine will increase the number of people who get vaccinated.

Eligible Conditions

Respiratory Infection
Influenza

LADHS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Receipt of the Annual Influenza Vaccine Among Adult Index Patients

Receipt of the Annual Influenza Vaccine Among Pediatric Index Patients

LADHS Trial Design

3Treatment groups

Active Control

Group I: Enhanced Bidirectional Text RemindersActive Control1 Intervention

Participants in this arm will receive a text message from a call center agent if they press "1" in response to a question on the original text message. The bidirectional texts will have an agent who can answer questions and schedule an appointment through text message back-and-forth conversations with the patient. Bidirectional texts will be exchanged on a HIPAA compliant bidirectional text messaging platform. The patient will use the regular SMS function on their cellphone and the agent will receive and respond to the bidirectional text on the HIPAA compliant platform.

Group II: Enhanced Text Reminders with Callback by PersonActive Control1 Intervention

Participants in this arm will receive up to 3 R/R messages by text. R/R message will receive a phone call back by a call center agent if they press "1" in response to a question on the original text message. The call center agent's job is to schedule patients for clinical visits. These call center agents will be trained by our faculty and staff and will have the usual HIPAA and other patient confidentiality training.

Group III: Standard Text RemindersActive Control1 Intervention

Participants in this arm will receive up to 3 text messages, reminding them about the importance of influenza vaccination. The standard texts will include a clinic call back number and patient portal self-scheduling for patients to schedule their influenza vaccines. The direct scheduling texts includes a direct number to an agent that can help schedule and answer questions on the phone in real time. The texts with a direct number to schedule will link a specified phone number to call and schedule. This number would be answered by a central agent quickly and a patient could schedule their flu shot at any clinic site. This specific phone number would not go through the multiple option menus a patient would normally experience when calling their clinic.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Los Angeles County Department of Public HealthOTHER_GOV

19 Previous Clinical Trials

300,913 Total Patients Enrolled

National Institute of Allergy and Infectious Diseases (NIAID)NIH

3,274 Previous Clinical Trials

5,238,065 Total Patients Enrolled

University of California, Los AngelesLead Sponsor

1,537 Previous Clinical Trials

10,021,205 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is registration for this research open at the present time?

"Affirmative. Clinicaltrials.gov has verified that this clinical trial, which was initially uploaded on September 13th 2022, is still recruiting patients. The study requires 250,000 individuals from 2 medical centres to participate."

Answered by AI

How many participants can enroll in this experiment?

"Affirmative. Information on clinicaltrials.gov confirms that the medical trial, which was first posted in September 13th of 2022, is currently recruiting patients. A total of 250 thousand individuals need to be enrolled across two sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)

Peter G Szilagyi, MD MPH 2022. "Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05535777.